Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy

Archive ouverte

Gauthier, Jordan | Damaj, Gandhi | Langlois, Carole | Robin, Marie | Michallet, Mauricette | Chevallier, Patrice | Beguin, Yves | Nguyen, Stephanie | Bories, Pierre | Blaise, Didier | Cornillon, Jerome | Clavert, Aline | Mohty, Mohamad | Huynh, Anne | Thiebaut-Bertrand, Anne | Vigouroux, Stephane | Duhamel, Alain | Yakoub-Agha, Ibrahim

Edité par CCSD -

International audience. The prognosis of myelodysplastic syndromes (MDS) after allogeneic stem cell transplantation is critically determined by cytogenetic abnormalities, as previously defined by International Prognostic Scoring System (IPSS) cytogenetics. It has been shown that a new cytogenetic classification, included in the IPSS-R (cytogenetic-IPSS-R [C-IPSS-R]), can better predict the outcome of untreated MDS patients.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion